Edition:
United States

BioScrip Inc (BIOS.OQ)

BIOS.OQ on NASDAQ Stock Exchange Global Select Market

3.01USD
16 Jul 2018
Change (% chg)

-- (--)
Prev Close
$3.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
171,803
52-wk High
$3.39
52-wk Low
$1.80

Latest Key Developments (Source: Significant Developments)

BioScrip Announces Additions To Senior Leadership Team
Tuesday, 28 Nov 2017 08:00am EST 

Nov 28 (Reuters) - BioScrip Inc ::BIOSCRIP ANNOUNCES ADDITIONS TO SENIOR LEADERSHIP TEAM.BIOSCRIP - ‍ANNOUNCED APPOINTMENTS OF HARRIET BOOKER AS CHIEF OPERATING OFFICER, DANNY CLAYCOMB AS SENIOR VICE PRESIDENT, REVENUE CYCLE MANAGEMENT​.  Full Article

Bioscrip reports qtrly ‍loss per share $0.12​
Thursday, 2 Nov 2017 08:00am EDT 

Nov 2 (Reuters) - Bioscrip Inc :Bioscrip reports third quarter 2017 financial results.Q3 revenue $198.7 million versus I/B/E/S view $200.9 million.Sees FY 2017 revenue $805 million to $810 million.Bioscrip Inc says ‍updated its adjusted EBITDA guidance to a range of $42.0 million to $44.0 million for full-year 2017​.Bioscrip Inc - Qtrly ‍loss per share $0.12​.Bioscrip Inc sees FY 2017 ‍loss per share in range of $0.58 to $0.64.FY2017 earnings per share view $-0.55, revenue view $824.5 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S.  Full Article

BioScrip can now dispense & administer radicava treatment option for amyotrophic lateral sclerosis
Thursday, 5 Oct 2017 08:00am EDT 

Oct 5 (Reuters) - Bioscrip Inc :BioScrip says can now dispense & administer Radicava (edaravone) treatment option for amyotrophic lateral sclerosis approved by U.S. FDA.  Full Article

Coliseum Capital reports 14.6 pct stake in Bioscrip
Friday, 8 Sep 2017 06:26am EDT 

Sept 8 (Reuters) - Bioscrip Inc :Coliseum Capital Management LLC reports 14.6 percent stake in Bioscrip Inc as of September 7, 2017 - SEC filing‍​.Coliseum Capital Management LLC earlier reported 16.5 percent stake in Bioscrip Inc as of August 17, 2017 - SEC filing‍​.  Full Article

U.S. files lawsuit against US Bioservices related to kickbacks, Novartis' Exjade
Tuesday, 22 Aug 2017 09:19am EDT 

Aug 22 (Reuters) - U.S. SAYS U.S. BIOSERVICES ARRANGED TO RECEIVE MORE PATIENT REFERRALS AND RELATED BENEFITS IN RETURN FOR ACHIEVING HIGHER PRESCRIPTION REFILL RATE FOR EXJADE:.  Full Article

BioScrip qtrly loss per share $0.26
Tuesday, 8 Aug 2017 08:00am EDT 

Aug 8 (Reuters) - BioScrip Inc :BioScrip reports second quarter 2017 financial results.Q2 revenue $218.1 million versus I/B/E/S view $220.2 million.Sees FY 2017 revenue $815 million to $835 million.Qtrly loss per share $0.26.Q2 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S.BioScrip Inc - is reiterating its prior guidance of adjusted ebitda in range of $45.0 million to $55.0 million for full-year 2017..BioScrip Inc - company expects to incur restructuring expenses in a range of $11.0 million to $12.0 million in 2017.FY 2017 revenue view $865.9 million -- Thomson Reuters I/B/E/S.  Full Article

Ares Management reports 9.2 pct stake in Bioscrip
Monday, 10 Jul 2017 07:04am EDT 

July 10 (Reuters) - Ares Management::Ares Management reports 9.2 pct stake in Bioscrip as of June 29 - SEC filing.Ares Management says the shares of Bioscrip Inc were acquired, and are currently held, for investment purposes.Ares Management - pursuant to agreement, Ares shall have right to appoint one non-voting board observer for so long as Ares holds debt of co of at least $50 million.  Full Article

BioScrip announces new senior note facilities
Thursday, 29 Jun 2017 08:30am EDT 

June 29 (Reuters) - BioScrip Inc ::BioScrip announces new senior note facilities.BioScrip Inc - under agreement, company entered into a $200 million first lien note facility and a $110 million second lien note facility.BioScrip Inc - to use proceeds of facilities to repay in full all amounts outstanding under its previous senior credit facilities and its priming credit agreement.BioScrip Inc - also as part of agreement, will receive a $16 million common stock investment, and will issue common stock warrants with a 10-year term..  Full Article

Bioscrip provides update on Unitedhealthcare contract
Tuesday, 30 May 2017 08:00am EDT 

May 30 (Reuters) - Bioscrip Inc :Bioscrip provides update on Unitedhealthcare contract.Bioscrip Inc - ‍reached an agreement to continue to provide certain core product lines to unitedhealthcare beyond September 30, 2017​.Bioscrip Inc says company is reiterating its prior guidance for adjusted EBITDA in range of $45.0 million to $55.0 million for full-year 2017.Bioscrip Inc - ‍with agreement, Bioscrip will retain approximately $35 million of annualized profitable core revenue​.  Full Article

Bioscrip reports first quarter 2017 financial results
Thursday, 4 May 2017 08:00am EDT 

May 4 (Reuters) - Bioscrip Inc : :Bioscrip reports first quarter 2017 financial results.Q1 revenue $217.8 million versus I/B/E/S view $229.7 million.Bioscrip Inc - reiterating its prior guidance of adjusted EBITDA in range of $45.0 million to $55.0 million for full-year 2017.Bioscrip Inc - qtrly loss per common share $0.18.Q1 earnings per share view $-0.15 -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $-0.36, revenue view $894.1 million -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-BioScrip Reports Qtrly Loss Per Share $0.12

* QTRLY LOSS PER SHARE $0.12 Source text for Eikon: Further company coverage: